Member of Lyonbiopole
ALPIONER Tx is a biotech company specializing in a new generation of immunotherapies leveraging the potential of a proprietary aT3-platform, a programmable Pa bacterial vector platform using the T3 Secretion System (T3SS), to boost the immune system against multiresistant pathogens and cancers.
Two lead candidates, ALP-102 is a first-in-class vaccine candidate targeting Pa infections in patients suffering from chronic respiratory diseases while ALP-201-neo is a personalized therapeutic cancer vaccine against solid tumors.
Our objective is to bring these two assets into clinical development by 2027.
Application market: Infectious Diseases, Oncology, Pneumology - Respiratory Diseases
Type of activity: Therapeutics, Pharma or Biotech
Technologies: Microbiology - probiotic - LBP, Molecular Biology & Nucleic acid, Vaccine
Created on nov. 28th, 2023 - 2 employees
Address
La petite Halle, 31 rue Gustave Eiffel 38000 Grenoble
Vous devez être connecté et membre de Lyonbiopôle pour voir les contacts.